Quốc gia: Vương quốc Anh
Ngôn ngữ: Tiếng Anh
Nguồn: myHealthbox
Fentanyl
Janssen-Cilag Ltd
N02A B03
Fentanyl
2.1 mg
Transdermal patch
Transdermal use
Five pouches
POM - Prescription Only Medicine
Janssen Pharmaceutica NV
Phenylpiperidine derivatives
In Adults: is indicated in the management of chronic intractable pain due to cancer; in the management of chronic intractable pain In Children:is indicated in long term management of severe chronic pain in children receiving opioid therapy from 2 years of age.
Authorised
2005-10-28
PACKAGE LEAFLET: INFORMATION FOR THE USER DUROGESIC ® _DTRANS_ ® TRANSDERMAL PATCH FENTANYL Durogesic and DTrans are registered trademarks IMPORTANT THINGS YOU NEED TO KNOW ABOUT DUROGESIC DTRANS TRANSDERMAL PATCHES • These patches contain a strong pain killer • Ensure that old patches are removed before applying a new one • Patches must not be cut • Do not expose the patches to a heat source (such as a hot water bottle) • If you develop a fever tell your doctor immediately • Follow the dosage instructions carefully and only change your patch every 3 DAYS (72 HOURS) • If your breathing becomes shallow and weak take the patch off and seek medical help THE REST OF THIS LEAFLET INCLUDES MORE DETAIL AND OTHER IMPORTANT INFORMATION ON THE SAFE AND EFFECTIVE USE OF THIS MEDICINE. • Keep this leaflet. You may need to read it again • If you have any further questions, ask your doctor, nurse or pharmacist • This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours • If you get side effects and they become serious or if you notice any side effects not listed in this leaflet, please tell your doctor, nurse or pharmacist IN THIS LEAFLET 1. What Durogesic DTrans patches are and what they are used for 2. Before you use Durogesic DTrans patches 3. How to use Durogesic DTrans patches 4. Possible side effects 5. How to store Durogesic DTrans patches 6. Further information 1. WHAT DUROGESIC DTRANS PATCHES ARE AND WHAT THEY ARE USED FOR The name of your medicine is Durogesic DTrans transdermal patch. It is called ‘Durogesic DTrans patch’ or just ‘patch’ in this leaflet. The patches help relieve pain Đọc toàn bộ tài liệu
Durogesic DTrans 12 mcg/hr Transdermal Patch Summary of Product Characteristics Updated 23Jul2015 | JanssenCilag Ltd 1. Name of the medicinal product Durogesic ® DTrans ® 12 mcg/hr Transdermal Patch 2. Qualitative and quantitative composition Each Durogesic DTrans 12 patch contains fentanyl 2.1 mg. Release rate approximately 12 µg/h; active surface area 5.25 cm 2 . For excipients, see 6.1 3. Pharmaceutical form Transdermal patch. Each patch is marked: Durogesic 12 µg fentanyl/h Orange printing ink 4. Clinical particulars 4.1 Therapeutic indications Adults: Durogesic DTrans is indicated in the management of chronic intractable pain due to cancer in the management of chronic intractable pain Children: long term management of severe chronic pain in children receiving opioid therapy from 2 years of age. 4.2 Posology and method of administration For transdermal use. Durogesic DTrans should be applied to nonirritated and nonirradiated skin on a flat surface of the torso or upper arm. In young children, the upper back is the preferred location to apply the patch, to minimise the potential of the child removing the patch. A nonhairy area should be selected. If this is not possible, hair at the application site should be clipped (not shaved) prior to application. If the site of Durogesic DTrans application requires to be cleansed prior to application of the patch, this should be done with water. Soaps, oils, lotions or any other agent that might irritate the skin or alter its characteristics should not be used. The skin should be completely dry before the patch is applied. Patches should be inspected prior to use. Patches that are cut, divided, or damaged in any way should not be used. The Durogesic DTrans patch should be removed from the protective Đọc toàn bộ tài liệu